RxDoctor Payments Data

Marcia Jones, MD

Family Medicine · Sterling, ILNPI 1114977063

Payments from drug & device makers

$1,212in general payments, 2019–2025

Across 16 payments — averaging $75.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$730
  • Bayer$145
  • Astellas Pharma US Inc$132
  • AstraZeneca$37
  • Phathom Pharmaceuticals, Inc.$32
  • Inspire Medical Systems, Inc.$30
  • plus $107 from 5 others

What the payments were for

  • Speaking & faculty fees$73060%
  • Food & beverage$38232%
  • Education$1008%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,212 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$125,171
Medicare patients
414
Services billed
2,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin162$164,504
EliquisApixaban200$155,711
MounjaroTirzepatide134$154,752
OzempicSemaglutide119$127,170
RybelsusSemaglutide51$81,942
FarxigaDapagliflozin Propanediol90$81,487
TrulicityDulaglutide86$73,968
Trelegy ElliptaFluticasone/Umeclidin/Vilanter101$70,828
VascepaIcosapent Ethyl45$32,056
Spiriva RespimatTiotropium Bromide42$31,660
XareltoRivaroxaban23$28,064
SymbicortBudesonide/Formoterol Fumarate57$25,521
Breo ElliptaFluticasone/Vilanterol47$24,174
Repatha SureclickEvolocumab24$16,651
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$14,884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$23$209,113170 claims
PfizerEliquis$19$155,711200 claims
AstraZenecaFarxiga, Symbicort$37$107,008147 claims
Johnson & JohnsonXarelto$26$28,06423 claims
Astellas Pharma US IncMyrbetriq$132$10,87216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Sterling

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →